Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

NCT07490509 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT07490509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07490509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer
Lead sponsor
Poitiers University Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2029
Enrollment
235 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

abemaciclib, abemaciclib-related diarrhea, breast cancer